Q. Wu

Impact of the combined timing of PD-1/PD-L1 inhibitors and chemotherapy on the outcomes in patients with refractory lung cancer

S. Jiao, X. Yan, M. Zhang, 2021, ESMO open.

Characteristics of liver fibrosis with different etiologies using a fully quantitative fibrosis assessment tool

H. You, Q. Wu, X. Zhao, 2017, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Characteristics of liver fi brosis with different etiologies using a fully quantitative fi brosis assessment tool

H. You, Q. Wu, X. Zhao, 2022 .

A blood-based miRNA signature predicts immunotherapy efficacy in advanced stage non-small cell lung cancer

K. Rabe, R. Horos, T. Sauka-Spengler, 2021, medRxiv.